Acetylcarnitine shuttling links mitochondrial metabolism to histone acetylation and lipogenesis.
Luke T IzzoSophie TrefelyChristina DemetriadouJack M DrummondTakuya MizukamiNina KuprasertkulAimee T FarriaPhuong T T NguyenNivitha MuraliLauren ReichDaniel S KantnerJoshua ShafferHayley C AffrontiAlessandro CarrerAndrew AndrewsBrian C CapellNathaniel W SnyderKathryn E WellenPublished in: Science advances (2023)
The metabolite acetyl-CoA is necessary for both lipid synthesis in the cytosol and histone acetylation in the nucleus. The two canonical precursors to acetyl-CoA in the nuclear-cytoplasmic compartment are citrate and acetate, which are processed to acetyl-CoA by ATP-citrate lyase (ACLY) and acyl-CoA synthetase short-chain 2 (ACSS2), respectively. It is unclear whether other substantial routes to nuclear-cytosolic acetyl-CoA exist. To investigate this, we generated cancer cell lines lacking both ACLY and ACSS2 [double knockout (DKO) cells]. Using stable isotope tracing, we show that both glucose and fatty acids contribute to acetyl-CoA pools and histone acetylation in DKO cells and that acetylcarnitine shuttling can transfer two-carbon units from mitochondria to cytosol. Further, in the absence of ACLY, glucose can feed fatty acid synthesis in a carnitine responsive and carnitine acetyltransferase (CrAT)-dependent manner. The data define acetylcarnitine as an ACLY- and ACSS2-independent precursor to nuclear-cytosolic acetyl-CoA that can support acetylation, fatty acid synthesis, and cell growth.
Keyphrases
- fatty acid
- induced apoptosis
- dna methylation
- cell cycle arrest
- histone deacetylase
- type diabetes
- endoplasmic reticulum stress
- squamous cell carcinoma
- deep learning
- machine learning
- insulin resistance
- signaling pathway
- drug delivery
- papillary thyroid
- reactive oxygen species
- cancer therapy
- adipose tissue
- skeletal muscle